Oncolytics Biotech Debt to Equity Ratio Analysis

Oncolytics Biotech Inc (ONCY)

1.04 0.00 (0.00%) USD | NASDAQ | Apr 19, 16:00

1.04 0.00 (0.00%) After-Hours: 19:47

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2000. Upgrade now.

Date	Value
September 30, 2007	0.00
June 30, 2007	0.00
March 31, 2007	0.00
December 31, 2006	0.0049
September 30, 2006	0.0042
June 30, 2006	0.0039
March 31, 2006	0.0036
December 31, 2005	0.0034
September 30, 2005	0.0046
June 30, 2005	0.0041
March 31, 2005	0.0038
December 31, 2004	0.0039
September 30, 2004	0.0054
June 30, 2004	0.005
March 31, 2004	0.0064
December 31, 2003	0.006

Date	Value
September 30, 2003	0.0073
June 30, 2003	0.0083
March 31, 2003	0.0096
December 31, 2002	0.0091
September 30, 2002	0.0099
June 30, 2002	0.0082
March 31, 2002	0.0102
December 31, 2001	0.0094
September 30, 2001	0.0089
June 30, 2001	0.008
March 31, 2001	0.00
December 31, 2000	0.0075
September 30, 2000	0.0074
June 30, 2000	0.008
March 31, 2000	0.0075

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

Acasti Pharma Inc	--
Aurinia Pharmaceuticals Inc	0.00
Edesa Biotech Inc	--
Lexaria Bioscience Corp	0.00
Xenon Pharmaceuticals Inc	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	29.26M
Total Liabilities (Quarterly)	8.486M
Shareholders Equity (Quarterly)	20.78M